RBC Capital Markets Initiates Coverage on McKesson Corporation (NYSE:MCK). What May be Next?





September 19, 2017 – By test







Investors sentiment decreased to 0.68 in Q4 2016. Its down 0.38, from 1.06 in 2016Q3. It turned negative, as 140 investors sold McKesson Corporation shares while 331 reduced holdings. 90 funds opened positions while 232 raised stakes. 178.60 million shares or 5.89% less from 189.78 million shares in 2016Q3 were reported.

Pggm Investments holds 369,521 shares. Green Square Ltd, Tennessee-based fund reported 1,474 shares. Amer Natl Registered Advisor Inc stated it has 0.12% of its portfolio in McKesson Corporation (NYSE:MCK). Moreover, Prudential Plc has 0% invested in McKesson Corporation (NYSE:MCK). Allen Investment Limited Liability holds 0.26% or 26,942 shares in its portfolio. Oak Associate Oh invested 0.36% of its portfolio in McKesson Corporation (NYSE:MCK). Cue holds 3,703 shares. Regent Inv Lc reported 0.96% of its portfolio in McKesson Corporation (NYSE:MCK). Da Davidson And Commerce owns 0% invested in McKesson Corporation (NYSE:MCK) for 1,447 shares. Salem Investment Counselors holds 16,780 shares or 0.27% of its portfolio. Gotham Asset Management Ltd Liability Corp has 277,057 shares for 0.5% of their portfolio. Moreover, Ct Mason has 0.25% invested in McKesson Corporation (NYSE:MCK) for 3,930 shares. Provise Grp Inc Ltd Liability Corp stated it has 0.06% of its portfolio in McKesson Corporation (NYSE:MCK). Numeric Invsts Lc stated it has 0.96% in McKesson Corporation (NYSE:MCK). Tompkins Fincl stated it has 0.03% of its portfolio in McKesson Corporation (NYSE:MCK).

Since March 28, 2017, it had 0 buys, and 5 sales for $24.77 million activity. $15.12 million worth of McKesson Corporation (NYSE:MCK) was sold by HAMMERGREN JOHN H on Tuesday, March 28.

Why Has RBC Capital Markets Given McKesson Corporation (NYSE:MCK) a $168.00 Price Target

Stock research analysts at RBC Capital Markets has a key “Sector Perform” rating for McKesson Corporation (NYSE:MCK). The firm initiated coverage in a research note shared with investors and clients on Tuesday morning. The PT would suggest upside of 12.36 % from the last close price.

Investors sentiment decreased to 0.68 in Q4 2016. Its down 0.38, from 1.06 in 2016Q3. It turned negative, as 140 investors sold McKesson Corporation shares while 331 reduced holdings. 90 funds opened positions while 232 raised stakes. 178.60 million shares or 5.89% less from 189.78 million shares in 2016Q3 were reported.

Pggm Investments holds 369,521 shares. Green Square Ltd, Tennessee-based fund reported 1,474 shares. Amer Natl Registered Advisor Inc stated it has 0.12% of its portfolio in McKesson Corporation (NYSE:MCK). Moreover, Prudential Plc has 0% invested in McKesson Corporation (NYSE:MCK). Allen Investment Limited Liability holds 0.26% or 26,942 shares in its portfolio. Oak Associate Oh invested 0.36% of its portfolio in McKesson Corporation (NYSE:MCK). Cue holds 3,703 shares. Regent Inv Lc reported 0.96% of its portfolio in McKesson Corporation (NYSE:MCK). Da Davidson And Commerce owns 0% invested in McKesson Corporation (NYSE:MCK) for 1,447 shares. Salem Investment Counselors holds 16,780 shares or 0.27% of its portfolio. Gotham Asset Management Ltd Liability Corp has 277,057 shares for 0.5% of their portfolio. Moreover, Ct Mason has 0.25% invested in McKesson Corporation (NYSE:MCK) for 3,930 shares. Provise Grp Inc Ltd Liability Corp stated it has 0.06% of its portfolio in McKesson Corporation (NYSE:MCK). Numeric Invsts Lc stated it has 0.96% in McKesson Corporation (NYSE:MCK). Tompkins Fincl stated it has 0.03% of its portfolio in McKesson Corporation (NYSE:MCK).

Since March 28, 2017, it had 0 buys, and 5 sales for $24.77 million activity. $15.12 million worth of McKesson Corporation (NYSE:MCK) was sold by HAMMERGREN JOHN H on Tuesday, March 28.

McKesson Corporation (NYSE:MCK) Ratings Coverage

Among 21 analysts covering McKesson Corporation (NYSE:MCK), 8 have Buy rating, 1 Sell and 12 Hold. Therefore 38% are positive. McKesson Corporation has $275 highest and $140 lowest target. $193.05’s average target is 29.25% above currents $149.36 stock price. McKesson Corporation had 61 analyst reports since July 31, 2015 according to SRatingsIntel. As per Tuesday, October 27, the company rating was maintained by Mizuho. The firm has “Buy” rating by Mizuho given on Wednesday, November 9. As per Friday, September 8, the company rating was upgraded by Needham. Mizuho maintained the shares of MCK in report on Thursday, August 11 with “Neutral” rating. FBR Capital maintained it with “Outperform” rating and $210.0 target in Tuesday, January 12 report. The firm has “Neutral” rating given on Tuesday, June 7 by Bank of America. The stock of McKesson Corporation (NYSE:MCK) earned “Neutral” rating by Robert W. Baird on Friday, October 28. Goldman Sachs downgraded the shares of MCK in report on Friday, September 16 to “Neutral” rating. The rating was maintained by JP Morgan on Tuesday, August 9 with “Overweight”. The firm earned “Mkt Outperform” rating on Wednesday, January 18 by Avondale.

About 1.12M shares traded. McKesson Corporation (NYSE:MCK) has declined 15.45% since September 19, 2016 and is downtrending. It has underperformed by 32.15% the S&P500.

Investors wait McKesson Corporation (NYSE:MCK) to report on October, 26. its quarterly earnings Wall Street analysts expect $2.78 earnings per share, down $0.16 or 5.44 % from last year’s $2.94 same quarter earnings. This translates into $584.53 million profit for MCK giving the stock a 13.41 P/E. This is assuming the current $2.78 EPS is accurate. McKesson Corporation’s Wall Street analysts see 13.01 % EPS growth, taking into account the $2.46 EPS reproted in the previous quarter,

McKesson Corporation is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The company has market cap of $31.40 billion. The Firm operates through two divisions: McKesson Distribution Solutions and Technology Solutions. It has a 6.65 P/E ratio. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.

More notable recent McKesson Corporation (NYSE:MCK) news were published by: Benzinga.com which released: “Analyst ‘Takes A Flyer’ On McKesson, Upgrades Ahead Of Earnings” on September 19, 2017, also Twst.com with their article: “McKesson Corporation: Southern Cancer Center is Global Leader in Kidney Cancer …” published on September 19, 2017, Seekingalpha.com published: “McKesson Ventures Leads $25 Million Financing Round For Truveris” on September 08, 2017. More interesting news about McKesson Corporation (NYSE:MCK) were released by: Seekingalpha.com and their article: “Long Term Still Bullish On McKesson” published on September 13, 2017 as well as Seekingalpha.com‘s news article titled: “McKesson Heavily Oversold At $147” with publication date: August 24, 2017.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *

*

15 + 11 =